• A 75-Year-Old Woman with a 5-Year History of Controlled Type 2 Diabetes Mellitus Presenting with Polydipsia and Polyuria and a Diagnosis of Central Diabetes Insipidus
• A novel <em>WFS1</em> variant associated with isolated congenital cataracts
• A novel <em>WFS1</em> variant associated with severe diabetic retinopathy in Wolfram syndrome type 1
• A novel WFS1 variant associated with severe diabetic retinopathy in Wolfram syndrome type 1
• A Pair of Siblings With Wolfram Syndrome: A Review of the Literature and Treatment Options
• A Wolfram-like syndrome family: Case report
• Advances in diagnosis and treatment of Wolfram syndrome and related molecular mechanism
• An adolescent male with persistent urinary symptoms
• An adolescent with Wolfram syndrome and central sleep apnea
• Astrocyte-mediated regulation of BLA^WFS1 neurons alleviates risk-assessment deficits in DISC1-N mice
• beta-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome
• Beyond Vision and Hearing: A Case Report of Wolfram Syndrome
• Cardiac Wolframinopathies: A Case Report of Myocarditis and a Literature Review of Cardiac Involvement in Wolfram Syndrome 1
• Case report: <em>De novo</em> pathogenic variant in <em>WFS1</em> causes Wolfram-like syndrome debuting with congenital bilateral deafness
• Case Report: A novel mutation in <em>WFS1</em> gene (c.1756G&gt;A p.A586T) is responsible for early clinical features of cognitive impairment and recurrent ischemic stroke
• Case report: De novo pathogenic variant in WFS1 causes Wolfram-like syndrome debuting with congenital bilateral deafness
• Chronic Stress Alters Hippocampal Renin-Angiotensin-Aldosterone System Component Expression in an Aged Rat Model of Wolfram Syndrome
• Cisd2 deficiency impairs neutrophil function by regulating calcium homeostasis via Calnexin and SERCA
• Clinical management and obstetric outcome in WFS1 Wolfram syndrome spectrum disorder: A case report and literature review
• Comprehensive Genetic Analysis Unraveled the Missing Heritability in a Chinese Cohort With Wolfram Syndrome 1: Clinical and Genetic Findings
• Comprehensive overview of disease models for Wolfram syndrome: toward effective treatments
• Continuous glycemic monitoring in managing diabetes in adult patients with wolfram syndrome
• Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma-1 receptor-positive modulator with cognitive and neuroprotective properties
• Coupling of autophagy and the mitochondrial intrinsic apoptosis pathway modulates proteostasis and ageing in Caenorhabditis elegans
• Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome
• Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum
• Depletion of WFS1 compromises mitochondrial function in hiPSC-derived neuronal models of Wolfram syndrome
• Dopamine D2 receptors in WFS1-neurons regulate food-seeking and avoidance behaviors
• Editorial: Debates in clinical management in pediatric endocrinology, volume II
• Editorial: Stars and rising stars in pediatric endocrinology: 2022
• Elevated intraneural vascularization of the median nerve proximal to the arteriovenous fistula in hemodialysis patients suspected of carpal tunnel syndrome: A case series
• Endoplasmic reticulum stress inhibition ameliorated WFS1 expression alterations and reduced pancreatic islets' insulin secretion induced by high-fat diet in rats
• Enhancement of taste by retronasal odors in patients with Wolfram syndrome and decreased olfactory function
• ER calcium depletion as a key driver for impaired ER-to-mitochondria calcium transfer and mitochondrial dysfunction in Wolfram syndrome
• Evaluation of the Oral Bacterial Genome and Metabolites in Patients with Wolfram Syndrome
• Family Planning in Genetic Optic Atrophies in Israel, a Case Series and a Discussion of Ethical Considerations
• Generation of induced pluripotent stem cells (IBMSi027-A) from a patient with hearing loss carrying WFS1 c.2051C &gt; T (p.Ala684Val) variant
• Genomics of Wolfram Syndrome 1 (WFS1)
• Genotype and Clinical Characteristics of Patients with Wolfram Syndrome and WFS1-related Disorders
• Genotype and clinical characteristics of patients with Wolfram syndrome and WFS1-related disorders
• GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder
• GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models
• GLP1 receptor agonists for Wolfram syndrome?
• High Frequency of Recessive WFS1 Mutations Among Indian Children With Islet Antibody-negative Type 1 Diabetes
• Identification of unique cell type responses in pancreatic islets to stress
• ISR inhibition reverses pancreatic beta-cell failure in Wolfram syndrome models
• ISR inhibition reverses pancreatic β-cell failure in Wolfram syndrome models
• Long term clinical follow up of four patients with Wolfram syndrome and urodynamic abnormalities
• MCT1-dependent energetic failure and neuroinflammation underlie optic nerve degeneration in Wolfram syndrome mice
• Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule
• Multidimensional analysis and therapeutic development using patient iPSC-derived disease models of Wolfram syndrome
• Multimodal imaging in autosomal dominant Wolfram syndrome and long-term follow-up of laminations of the outer plexiform layer
• NCS1 overexpression restored mitochondrial activity and behavioral alterations in a zebrafish model of Wolfram syndrome
• Neuro-Ophthalmologic Variability in Presentation of Genetically Confirmed Wolfram Syndrome: A Case Series and Review
• Neuroimaging features in Wolfram syndrome type 1
• Neurosensory Affectation in Patients Affected by Wolfram Syndrome: Descriptive and Longitudinal Analysis
• New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer's disease?
• Next Generation Sequencing (NGS) Target Approach for Undiagnosed Dysglycaemia
• Next generation sequencing identifies a pathogenic mutation of WFS1 gene in a Moroccan family with Wolfram syndrome: a case report
• Novel WFS1 Variants in Two Moroccan Families with Wolfram Syndrome
• Optic Nerve T2 Signal Intensity and Caliber Reflect Clinical Severity in Genetic Optic Atrophy
• Overlap between ophthalmology and psychiatry - A narrative review focused on congenital and inherited conditions
• Paediatric Wolfram syndrome Type 1: should gonadal dysfunction be part of the diagnostic criteria?
• Peculiar Outer Plexiform Layer in Autosomal Dominant Wolfram Syndrome
• Predictions of the Poses and Affinity of a Ligand over the Entire Surface of a NEET Protein: The Case of Human MitoNEET
• Psychiatric Diagnoses and Medications in Wolfram Syndrome
• Rejuvenation: Turning Back Time by Enhancing CISD2
• Repetitive Suicidal Behaviors in a Case With a New Mutation of Wolfram Syndrome: A Jump From the Gene to the Behavior
• Rescue of Long-Term Spatial Memory by 7,8-Dihydroxyflavone in Mice with Reduced Oligodendrogenesis
• Selective proteasome degradation of C-terminally-truncated human WFS1 in pancreatic beta cells
• Sequential Presentation of Obsessive-Compulsive Disorder and Narcolepsy in a 10-Year-Old Girl With Wolfram Syndrome 1
• Targeting Ca²⁺-dependent pathways to promote corneal epithelial wound healing induced by CISD2 deficiency
• The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network
• The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes
• The miR-668 binding site variant rs1046322 on <em>WFS1</em> is associated with obesity in Southeast Asians
• The Role of ER Stress in Diabetes: Exploring Pathological Mechanisms Using Wolfram Syndrome
• The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice
• Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndrome
• There's More Than Meets the Eye: Wolfram Syndrome in a Type I Diabetic Patient
• Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders
• Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram Syndrome
• Two cases of Wolfram syndrome
• Variants of <em>WFS1</em> identified by whole exome sequencing in a boy with Wolfram syndrome 1: A case report
• Variants of WFS1 identified by whole exome sequencing in a boy with Wolfram syndrome 1: A case report
• WFS1 autosomal dominant variants linked with hearing loss: update on structural analysis and cochlear implant outcome
• Wfs1 loss-of-function disrupts the composition of mouse pancreatic endocrine cells from birth and impairs Glut2 localization to cytomembrane in pancreatic β cells
• Wfs1^E864K knock-in mice illuminate the fundamental role of Wfs1 in endocochlear potential production
• Whole-exome sequencing reveals novel variants of monogenic diabetes in Tunisia: impact on diagnosis and healthcare management
• Wolfram Syndrome 1 in Two Brothers Treated with Insulin Pump
• Wolfram syndrome 1 regulates sleep in dopamine receptor neurons by modulating calcium homeostasis
• Wolfram Syndrome 1: A Pediatrician's and Pediatric Endocrinologist's Perspective
• Wolfram syndrome 1b mutation suppresses Mauthner-cell axon regeneration via ER stress signal pathway
• Wolfram syndrome in a young woman with associated hypergonadotropic hypogonadism - A case report
• Wolfram syndrome type 1: a case series
• Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants
• Wolfram Syndrome-2, a Cause of Severe Gastrointestinal Bleeding: A Case Series and a Literature Review
• Wolfram Syndrome: A Curious Case of Repetitive Loss of Consciousness
• Wolfram Syndrome: Only a Neurodegenerative Disease or Also a Maculopathy?
• Wolfram-like syndrome: a case report
• β-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome